Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-02-15Clinical Trial Update: Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL [Phase 2]
A Phase 2 trial evaluating a single dose of 90Y-ibritumomab tiuxetan in patients with low tumor burden, untreated or indolent non-Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy [Phase 2]
This Phase 2 study from Memorial Sloan Kettering Cancer Center evaluated a myeloablative conditioning regimen with total body irradiation fo…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial results for lenalidomide, rituximab, cyclophosphamide, and dexamethasone in previously untreated low-grade non-Hodgkin lymphom…
-
CLINICAL_TRIALS withdrawal · 2016-02-03Clinical Trial Update: Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating a chemotherapy regimen followed by Rituximab and Yttrium-90 ibritumomab tiuxetan for AIDS-related Non-Hodgkin lymph…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update examining chemotherapy, radiation therapy, rituximab, and umbilical cord blood transplantation for B-cell non-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor [Phase 2]
Phase II study evaluating a myeloablative conditioning regimen of busulfan, melphalan, and fludarabine followed by an allogeneic hematopoiet…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT [NA]
This trial assessed whether rituximab (Rituxan) can prevent EBV-associated lymphoproliferative disorder after T-cell-depleted unrelated or H…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab
A completed clinical trial update on patients with low-grade Non-Hodgkin lymphoma treated with iodine-131 labeled tositumomab.
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CD30-directed CAR-T therapy (CART30) for relapsed/refractory CD30-positive lymphomas is currently recr…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma [Phase 2]
Phase 2 trial update for LSA4 protocol in advanced pediatric and adolescent Non-Hodgkin's Lymphoma completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in combination with outpatient therapy for CD20+ non-Hodgkin lymphoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases [Phase 2]
Phase 2 trial evaluating total body irradiation with fludarabine-based conditioning followed by haploidentical transplantation for hematolog…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Efficacy Study of Outpatient Therapy for Lymphoma [Phase 2]
A Phase 2 efficacy trial evaluating outpatient therapy for lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma [Phase 2]
A Phase 2 clinical trial evaluated the efficacy and treatment-related toxicity of a new regimen for lymphoma, including Non-Hodgkin's Lympho…
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 safety and efficacy study of AME-133v, an anti-CD20 monoclonal antibody, for Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma [Phase 2]
Phase 2 trial evaluating bendamustine, bortezomib, and rituximab in previously untreated low-grade non-Hodgkin lymphoma has completed, with …
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Spectroscopy With Surface Coils and Decoupling [Phase 1]
A Phase 1 clinical trial evaluating spectroscopy with surface coils and decoupling has completed, across multiple cancer indications. Sponso…
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: The Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment Planning [Phase 1]
This entry reports a Phase 1 clinical trial evaluating breathing-synchronized CT and PET scans to guide radiation therapy planning. The spon…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluated GM-CSF and rituximab after autologous stem cell transplant in patients with relapsed or refractory follicular non-…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma [Phase 3]
Phase 3 randomized trial comparing tacrolimus/sirolimus/methotrexate to tacrolimus/methotrexate or cyclosporine/mycophenolate mofetil for GV…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT [NA]
This completed clinical trial evaluates whether FDG PET imaging can predict residual disease. It also examines subsequent relapse in patient…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [NA]
ClinicalTrials.gov update indicates completion of a study assessing cytogenetic analysis of bone marrow before high-dose chemotherapy and au…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy
A completed clinical trial update assessing structural brain imaging and cognitive function in adult stem cell transplant recipients treated…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Anti-Tac labeled with Yttrium-90 (90Y-HAT) for Hodgkin lymphoma, Non-Hodgkin lymphoma, and lymphoid leuk…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of obatoclax with bortezomib in adults with aggressive relapsed or recurrent non-Hodgkin lymphoma has been terminated.